Viking Therapeutics, Inc. (VKTX)
29.94
-0.57
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
30.00
+0.06
(+0.20%)
After-Hours: 20:00
Viking Therapeutics Price to Book Value : 8.554 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 8.554 |
| October 01, 2026 | 8.716 |
| September 30, 2026 | 9.314 |
| September 29, 2026 | 9.088 |
| September 28, 2026 | 9.436 |
| September 25, 2026 | 10.16 |
| September 24, 2026 | 10.50 |
| September 23, 2026 | 11.90 |
| September 22, 2026 | 11.67 |
| September 21, 2026 | 8.602 |
| September 18, 2026 | 8.282 |
| September 17, 2026 | 8.388 |
| September 16, 2026 | 8.434 |
| September 15, 2026 | 8.556 |
| September 14, 2026 | 9.008 |
| September 11, 2026 | 9.136 |
| September 10, 2026 | 9.179 |
| September 09, 2026 | 9.342 |
| September 08, 2026 | 9.622 |
| September 04, 2026 | 9.962 |
| September 03, 2026 | 9.708 |
| September 02, 2026 | 9.571 |
| September 01, 2026 | 9.619 |
| August 31, 2026 | 9.365 |
| August 28, 2026 | 9.188 |
| Date | Value |
|---|---|
| August 27, 2026 | 9.674 |
| August 26, 2026 | 9.822 |
| August 25, 2026 | 9.762 |
| August 24, 2026 | 9.494 |
| August 21, 2026 | 9.682 |
| August 20, 2026 | 9.816 |
| August 19, 2026 | 10.28 |
| August 18, 2026 | 9.534 |
| August 17, 2026 | 9.608 |
| August 14, 2026 | 9.482 |
| August 13, 2026 | 9.411 |
| August 12, 2026 | 9.719 |
| August 11, 2026 | 9.656 |
| August 10, 2026 | 9.839 |
| August 07, 2026 | 9.788 |
| August 06, 2026 | 9.514 |
| August 05, 2026 | 9.574 |
| August 04, 2026 | 9.411 |
| August 03, 2026 | 9.316 |
| July 31, 2026 | 9.068 |
| July 30, 2026 | 9.459 |
| July 29, 2026 | 9.551 |
| July 28, 2026 | 9.674 |
| July 27, 2026 | 9.962 |
| July 24, 2026 | 9.939 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.315 |
| Eli Lilly & Co. | 31.76 |
| Regeneron Pharmaceuticals, Inc. | 2.397 |
| Amgen, Inc. | 18.64 |
| Ironwood Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.0315 |
| Price | 29.94 |
| Earnings Yield | -15.57% |
| Market Cap | 3.493B |
| PEGY Ratio | -0.0315 |